KULKARNI SAMARTH (Chief Executive Officer) sold 3.0% of their position (6.97K shares) of CRISPR THERAPEUTICS AG on the open market
Open‑market sale worth $366.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/20/2026ACC: 0001193125-26-061712
DirectorOfficer· Chief Executive Officer
Since Sep 2018
-6.97K
Net shares
Net seller
$366.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
13.25K acquired · 20.22K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+13.25K
Price / share
—
Trade value
—
% of position
6.0%
2/18/2026
219.82K→233.07K
Common Shares
Direct
Shares
−6.97K
Price / share
$52.58
Trade value
$366.32K
% of position
3.0%
2/19/2026
233.07K→226.11K
Total
Net shares
+6.28K
Net value
-$366.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 2/18/2026 | M · Option Exercise | +13.25K | — | — | 6.0% | 219.82K | 233.07K |
| Common Shares Direct | 2/19/2026 | S · Sale | −6.97K | $52.58 | $366.32K | 3.0% | 233.07K | 226.11K |
| Total | +6.28K | -$366.32K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Shares
13.25K shares
Shares
−13.25K
Strike price
Held after
0.00
Exercisable
—
2/18/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Shares13.25K shares | 2/18/2026 | M · Option Exercise | −13.25K | — | 0.00 |